Intellectual Property India Publishes Patent Application for 'Nootkatone For The Treatment Of Pruritus' Filed by Enveda Therapeutics, Inc.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517058662 A) filed by Enveda Therapeutics, Inc., Boulder, U.S.A., on June 18, for 'nootkatone for the treatment of pruritus.'

Inventor(s) include Colluru, Viswa; Wee, Daniel; Gaetz, Matthew; Gordon, Hannah; Yu, Marvin; and Deeg, Mark.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates generally to compounds, compositions, and methods for treating pruritus using a therapeutically effective amount of nootkatone, a pharmaceutically acceptable salt or derivative thereof. Methods of formulating and using the compositions are also provided."

The patent application was internationally filed on Dec. 05, 2023, under International application No.PCT/US2023/082590.

Disclaimer: Curated by HT Syndication.